Delivery Order SPE2DR25D3201-SPE2DR26FT7VB

The Defense Logistics Agency issued a $29,683.80 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for HYPERRAB 300 unit/mL vial 5 mL, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999.00 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...

The Defense Logistics Agency issued a $8,245.50 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for HYPERRAB 300 unit/ml vial 5ml pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5mL. This is a firm fixed-price delivery order under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for HYPERRAB 300 Unit/ML vial medication with a ceiling value of $1,895.04.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of April 2, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $49,473 delivery order to AmerisourceBergen Drug Corp on February 24, 2026, for HYPERRAB 300 unit/mL vial 5 mL pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 17, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, with a ceiling value of $6,316.80 for HYPERRAB 300 unit/mL vial pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 16, 2026. Pricing is firm fixed price. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $3,158.40 (firm fixed price) under the DLA Troop Support Medical indefinite delivery contract for HYPERRAB 300 unit/ml vial pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>

The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,079.06 for HYPERRAB 300 Unit/ML Vial on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a small-value pharmaceutical procurement supporting federal...

The Defense Logistics Agency awarded a $3,465.10 delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for HYPERRAB 300 Unit/ML vials, with a completion date of May 27, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. HYPERRAB is a rabies immune globulin product used for post-exposure prophylaxis in military and federal healthcare settings. This...

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HYPERRAB 300 Unit/ML Vials. This firm fixed-price delivery order, valued at $3,354.60, represents a non-competitive set-aside award and is scheduled for ultimate completion by January 22, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...